Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
Author:
Funder
Helse Nord RHF
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference90 articles.
1. IBD pathogenesis in 2014: molecular pathways controlling barrier function in IBD;Atreya;Nat Rev Gastroenterol Hepatol,2015
2. A systematic review of epidemiology and risk factors associated with Chinese inflammatory Bowel disease;Cui;Front Med,2018
3. Epidemiology and risk factors for IBD;Ananthakrishnan;Nat Rev Gastroenterol Hepatol,2015
4. A review on the use of anti-TNF in children and adolescents with inflammatory Bowel disease;Aardoom;Int J Mol Sci,2019
5. Can we predict the efficacy of anti-TNF-α agents?;Lopetuso;Int J Mol Sci,2017
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The gut barrier as a gatekeeper in colorectal cancer treatment;Oncotarget;2024-08-14
2. Systematic review: effectiveness and safety of switching between originator infliximab and biosimilar infliximab in patients with inflammatory bowel disease;Expert Opinion on Biological Therapy;2024-07-02
3. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options;International Journal of Molecular Sciences;2024-06-27
4. Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease;Inflammation Research;2024-06-06
5. Cytokine Signatures in Inflamed Mucosa of IBD Patients: State-of-the-Art;Gastroenterology Insights;2024-06-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3